ARRAKIS THERAPEUTICS Trademark

Trademark Overview

On Tuesday, October 20, 2020, a trademark application was filed for ARRAKIS THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ARRAKIS THERAPEUTICS trademark a serial number of 90265729. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Wednesday, September 4, 2024. This trademark is owned by Arrakis Therapeutics, Inc. The ARRAKIS THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, small-molecule drugs
arrakis therapeutics

General Information

Serial Number90265729
Word MarkARRAKIS THERAPEUTICS
Filing DateTuesday, October 20, 2020
Status734 - FIFTH EXTENSION - GRANTED
Status DateWednesday, September 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 25, 2022

Trademark Statements

Description of MarkThe mark consists of three differently sized sets of concentric circles, with a thick striped line connecting the first and second circles and the second and third circles. The wording "Arrakis Therapeutics" appears to the right of the design, with "arrakis" in large, prominent, lowercase type above and "therapeutics" in smaller, all-capitalized type below.
Goods and ServicesPharmaceutical preparations, namely, small-molecule drugs
NOT AVAILABLE"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 8, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameArrakis Therapeutics, Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451
Party NameArrakis Therapeutics, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451

Trademark Events

Event DateEvent Description
Friday, October 23, 2020NEW APPLICATION ENTERED
Tuesday, December 8, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 9, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, March 20, 2021ASSIGNED TO EXAMINER
Monday, September 27, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, March 27, 2021NON-FINAL ACTION WRITTEN
Saturday, March 27, 2021NON-FINAL ACTION E-MAILED
Saturday, March 27, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 27, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 27, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 8, 2021ASSIGNED TO EXAMINER
Sunday, December 19, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 5, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 22, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 25, 2022PUBLISHED FOR OPPOSITION
Tuesday, January 25, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, July 28, 2022SOU TEAS EXTENSION RECEIVED
Thursday, July 28, 2022SOU EXTENSION 1 FILED
Thursday, July 28, 2022SOU EXTENSION 1 GRANTED
Saturday, July 30, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 3, 2023SOU TEAS EXTENSION RECEIVED
Friday, March 3, 2023SOU EXTENSION 2 GRANTED
Friday, March 3, 2023SOU EXTENSION 2 FILED
Friday, September 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 6, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, September 6, 2023SOU EXTENSION 3 FILED
Wednesday, September 6, 2023SOU EXTENSION 3 GRANTED
Wednesday, February 21, 2024SOU EXTENSION 4 GRANTED
Wednesday, February 21, 2024SOU EXTENSION 4 FILED
Wednesday, February 21, 2024SOU TEAS EXTENSION RECEIVED
Thursday, February 22, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 4, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, September 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 4, 2024SOU EXTENSION 5 GRANTED
Wednesday, September 4, 2024SOU EXTENSION 5 FILED

Related Keywords

therapeutics arrakis molecule drugs small namely preparations pharmaceutical